Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amimestrocel - Platinum Life Excellence Biotech

Next Previous
Drug Profile

Amimestrocel - Platinum Life Excellence Biotech

Alternative Names: hUC-MSC-PLEB001; Ruibosheng

Latest Information Update: 18 Feb 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Platinum Life Excellence Biotech
  • Class Mesenchymal stem cell therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Graft-versus-host disease

Most Recent Events

  • 10 Feb 2026 The First Affiliated Hospital of Soochow University plans a phase II trial for Mucositis (Prevention) (IV) (NCT07400328)
  • 06 Dec 2025 Efficacy and adverse events data from a phase II trial in Graft-versus-host disease presented at the 67th American Society of Hematology Annual Meeting and Exposition (ASH 2025)
  • 15 May 2025 Platinum Life Excellence Biotech plans a phase II trial in Diabetic nephropathy in China (IV, Infusion) in May 2025 (NCT06969807)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top